U.S. Tobacco Stock News

Canadian Solar reported third-quarter 2025 revenue of US$1.49 billion, exceeding analyst forecasts, alongside a return to net income despite a slight year-over-year sales decline. Recent large-scale energy storage contract wins in Canada, Germany, and Australia highlight momentum in the company’s e-STORAGE segment, with a contracted backlog of US$3.1 billion as of June 2025. We'll consider how Canadian Solar’s strong e-STORAGE results and new contracts could influence its long-term earnings...

Wetteri recently expanded its partnership with Polestar by opening a full-service Polestar store in Kuopio, Finland, offering sales, maintenance, and spare parts, with an official launch on November 6, 2025, and future coverage planned for both Kuopio and Oulu locations. This regional retail expansion coincides with Polestar’s broader efforts to strengthen its European footprint and service network at a time when its operational performance is under increased scrutiny. We'll examine how...

Jacobs, in joint venture with AECOM, announced their appointment by New Murabba Development Company to provide design services for The Mukaab, a landmark centerpiece of Riyadh's New Murabba development and part of Saudi Arabia's Vision 2030 initiative. This collaboration places AECOM at the forefront of one of the largest global urban development projects, reflecting increased demand for sustainable and innovative infrastructure solutions in international markets. We'll examine how AECOM's...

CTS Corporation (CTS) just rolled out a fresh $100 million share repurchase plan with no set expiration, coinciding with the appointment of Kimberly Banks MacKay to the Board. Both moves highlight the company’s active approach to capital allocation and leadership strategy. See our latest analysis for CTS. The fresh $100 million buyback plan and addition of a seasoned board member landed as CTS's share price recovers modestly from its recent lows. Despite a strong 7-day move and a 30-day share...

Sabra Health Care REIT (SBRA) has recently attracted attention as investors dig into its performance over the past month, with the stock advancing almost 6%. This steady upward movement has prompted some investors to revisit their expectations for the real estate investment trust. See our latest analysis for Sabra Health Care REIT. After climbing nearly 6% over the past month, Sabra Health Care REIT is showing signs of renewed momentum, building on a 9% share price return year-to-date and an...

Broadridge Financial Solutions (BR) caught investor attention this week as the company shared results from its latest investor presentation, reaffirmed fiscal 2026 guidance, and announced a continued quarterly cash dividend. Ongoing leadership moves also highlight its ambitions abroad. See our latest analysis for Broadridge Financial Solutions. Broadridge’s recent executive appointment, strong quarterly results, and ongoing buybacks have kept the spotlight on the company; however, the share...

Earlier in November 2025, KeyBanc analyst Philip Gibbs upgraded ATI, highlighting the company's robust performance in core EBITDA margins and anticipated growth in aerospace and defense sales. An interesting dimension is ATI's specialized materials portfolio, which may benefit from increased nuclear sector demand, while its strong free cash flow outlook could support renewed share buybacks. We'll explore how the analyst's recognition of margin strength and free cash flow potential could...

Microsoft recently reported strong quarterly earnings growth, fueled by accelerated demand for Azure and AI-powered cloud services, alongside expanding enterprise adoption of its AI solutions and infrastructure. This performance was further supported by significant investments in new AI data centers, continued momentum around major partnerships, and a robust backlog, underscoring the company's rapidly growing presence in the enterprise AI ecosystem. We'll examine how Microsoft's large-scale...

Pulse Biosciences (PLSE) shares have edged up slightly in recent trading, gaining just under 2% following a stretch of losses this month. The move comes as investors reassess the company’s outlook in light of continued volatility in the healthcare sector. See our latest analysis for Pulse Biosciences. This latest rebound offers a bit of relief for Pulse Biosciences after a tough run that saw the share price slump over the past month. The company’s three-year total shareholder return is still...

Virtus Investment Partners (VRTS) shares have come under pressure over the past month, declining 16%. Investors are taking a closer look at the stock’s trajectory and considering potential catalysts that could shape its direction. See our latest analysis for Virtus Investment Partners. After a tough 30-day stretch for Virtus Investment Partners, with a share price return of -15.5%, the year-to-date slide has extended to -26.1%. Momentum looks decidedly challenged, and the past year’s total...

Earlier this month, Molson Coors Beverage Company reported third-quarter results with sales and revenue declining year-over-year, issued lowered full-year guidance anticipating a 3% to 4% net sales drop, and disclosed large impairment charges totaling over US$3.9 billion. A significant non-cash goodwill impairment led to a net loss for the period, highlighting ongoing operational pressures despite ongoing share buybacks and director share purchases. We'll explore how the recent goodwill...

Borr Drilling Limited recently reported its third quarter 2025 results, posting US$277.1 million in revenue and US$27.8 million in net income, both increasing significantly from the same period last year. An unusually high rig utilization rate and continued contract wins, particularly in markets like Saudi Arabia and Mexico, highlight robust operational momentum for the company. We'll examine how Borr Drilling's increased rig activity and new contract commitments could affect the company's...

DexCom (DXCM) is facing a major legal and regulatory challenge as recent lawsuits claim unauthorized design changes to its G6 and G7 glucose monitors have led to decreased reliability and possible health risks. The FDA has issued a Warning Letter, and these developments have drawn serious attention from both investors and healthcare users. See our latest analysis for DexCom. The regulatory and legal turbulence has clearly fed into DexCom’s share price, which is now down to $58.06 after a...

In recent days, Charles Schwab reported record net new assets of US$44.4 billion in October, with total client assets reaching US$11.83 trillion, alongside a completed US$1 billion fixed-income offering and confirmation of acquiring Forge Global, a private share marketplace, to broaden investor access to private markets. This surge in client engagement, highlighted by a very large year-over-year jump in new account openings, reveals strong operational momentum as Schwab continues to benefit...

Earlier this month, Dave Inc. reported third-quarter 2025 earnings with revenue of US$150.73 million and net income of US$92.07 million, both showing very large increases compared to a year ago, and raised its full-year revenue guidance to US$544 million–US$547 million, up from previous expectations. The company credited its outperformance to higher member monetization driven by a mandatory fee structure and continued product innovation, indicating effective operational changes are...

Curious if Phillips 66 is undervalued or set for a breakout? You're not alone, especially as energy stocks continue to capture investor attention. The stock has shown some serious momentum lately, rising 3.2% in the last week and almost 10% over the last month. It is also up 24.4% year-to-date and 12.8% over the past year. Recent headlines highlight increased refinery utilization rates and strategic investments in renewable fuels, which have boosted market confidence in the company's...

Northrop Grumman (NOC) has seen shares trade flat in recent sessions, prompting investor interest in how the defense contractor’s fundamentals are currently stacking up. With revenue and net income growth just above 5% over the past year, the stock’s performance invites a closer look at the underlying value drivers. See our latest analysis for Northrop Grumman. After a strong run earlier this year, Northrop Grumman’s share price has pulled back 8.36% over the past month but remains up more...

NGL Energy Partners (NGL) delivered a standout set of results for the second quarter, surpassing earnings and revenue expectations. Higher water volumes and strong Grand Mesa segment growth were central to this performance, along with new long-term contracts and expanded commitments. See our latest analysis for NGL Energy Partners. Following its upbeat earnings release and an active share buyback program, NGL Energy Partners has captured investor attention in a big way. Momentum is building,...

Healthcare Services Group (HCSG) has caught the eye of investors following a sustained rally over the past month. The stock has gained more than 5% in that period, bringing its year-to-date return to over 51%. See our latest analysis for Healthcare Services Group. The latest surge in Healthcare Services Group’s share price builds on months of accelerating momentum, suggesting renewed optimism around its growth story. With a 51.4% year-to-date share price return and a 1-year total shareholder...

In early November 2025, First Watch Restaurant Group completed a follow-on equity offering of 5,289,784 common shares for US$93.70 million and updated its financial guidance alongside reporting third quarter results. This series of announcements highlights the company's commitment to funding expansion plans while maintaining steady revenue growth projections and investing in new restaurant openings. We will explore how First Watch Restaurant Group's capital raise and updated expansion goals...

FedEx (FDX) shares have displayed steady movement recently, catching the eye of investors interested in the shipping giant’s longer-term performance. With the stock up 13% over the past month, many are taking a closer look at the underlying trends. See our latest analysis for FedEx. The recent 13% jump in FedEx’s share price over the past month stands out, especially after a choppier start to the year. While year-to-date returns remain slightly negative, the company’s three-year total...

S&P Global Inc. recently announced a new share repurchase program, authorizing the buyback of up to 30,000,000 shares as approved by its Board of Directors. The company's decision to repurchase shares often reflects management’s confidence in the business and can lead to enhanced value for existing shareholders. We’ll explore how the substantial buyback authorization may strengthen S&P Global’s investment narrative and shareholder value proposition. Outshine the giants: these 25 early-stage...

On November 13, 2025, VeriSign's Executive Chairman, President, and CEO, D Bidzos, sold 9,000 shares of the company according to an SEC filing. This sale adds to a pattern of insider selling, as the CEO has sold a total of 108,000 shares over the past year without making any purchases, highlighting ongoing executive share sales. We'll now examine how recent insider selling by VeriSign's CEO may influence the company's investment narrative and investor confidence. Find companies with...

Wondering if NVIDIA's meteoric rise is justified, or if all the excitement has pushed the stock beyond its true value? You're not alone. Figuring out what the company is really worth has become a hot topic for investors and curious market-watchers alike. NVIDIA's stock has surged 37.5% year-to-date and more than doubled over the last three years, suggesting there could be both growing optimism and higher expectations built into the price. This momentum hasn't come out of nowhere. Fresh...